Sanofi Underplayed Dangers Of Chemo Drug, Suit Says
Law360, New York (March 15, 2016, 8:44 PM EDT) -- Sanofi SA knew that its breast cancer treatment drug Taxotere was more dangerous than its competitors’ products and frequently caused permanent hair loss, but went to great lengths to hide the problem and promote the drug’s alleged superiority, a California woman said in a federal lawsuit filed Friday.
Ami Dodson, who says Sanofi, Aventis Pharma SA and Sanofi-Aventis US LLC engaged in a long-running scheme to drive up Taxotere sales — a plan that caused thousands of patients to be exposed to the drug’s increased toxicity when compared to other similar medications, as well as additional side effects including permanent hair...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!